Evidence map›Paper›PMID 41384453›Full record

ArticleBJPsych open2025

Confirmatory factor analysis of competing PANSS negative symptom models: data from OPTiMiSE first-episode schizophrenia study.

Arsime Demjaha, Daniel Stahl, Celso Arango, Birte Glenthøj, Roberto Rodriguez-Jimenez, Covadonga Martinez Díaz-Caneja, Lone Baandrup, Bjørn Ebdrup, Maria Paz Garcia-Portlla, Maria Diaz-Marsa and 4 more

Abstract read
In one paragraph

Article in BJPsych open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Arsime DemjahaDepartment of Psychosis Studies, https://ror.org/0220mzb33Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0002-1870-6410
Daniel StahlDepartment of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Celso ArangoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Gregorio Marañón General University Hospital, Health Research Institute Gregorio Marañón (IiSGM), Biomedical Research Networking Centre in Mental Health (CIBERSAM), School of Medicine, Complutense University of Madrid, Madrid, Spain.
Birte GlenthøjCenter for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark.
Roberto Rodriguez-JimenezComplutense University of Madrid, Madrid, Spain.
Covadonga Martinez Díaz-CanejaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Gregorio Marañón General University Hospital, Health Research Institute Gregorio Marañón (IiSGM), Biomedical Research Networking Centre in Mental Health (CIBERSAM), School of Medicine, Complutense University of Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0001-8538-3175
Lone BaandrupCenter for Neuropsychiatric Schizophrenia Research (CNSR) and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-1662-2720
Bjørn EbdrupCenter for Neuropsychiatric Schizophrenia Research (CNSR), Mental Health Center Glostrup, Copenhagen University Hospital, Mental Health Services CPH, Copenhagen, Denmark.
Maria Paz Garcia-PortllaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Gregorio Marañón General University Hospital, Health Research Institute Gregorio Marañón (IiSGM), Biomedical Research Networking Centre in Mental Health (CIBERSAM), School of Medicine, Complutense University of Madrid, Madrid, Spain.
Maria Diaz-MarsaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Gregorio Marañón General University Hospital, Health Research Institute Gregorio Marañón (IiSGM), Biomedical Research Networking Centre in Mental Health (CIBERSAM), School of Medicine, Complutense University of Madrid, Madrid, Spain.
Inge Winter-van RossumDepartment of Psychiatry, Brain Center Rudolf Magnus, Utrecht, The Netherlands.
Rene KahnDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Paola DazzanDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Philip McGuireDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0003-4381-0532

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe negative symptoms of psychosis are heterogeneous, which complicates efforts to understand their pathophysiology and develop effective treatments. Factor analytic studies of the Positive and Negative Syndrome Scale (PANSS) have reported two factorial negative symptom models, expressive deficit and social amotivation, albeit with different compositions. Although models derived from other assessment scales have been directly compared, no study has previously applied this approach to PANSS.

aimsOur objectives were to (a) to establish which negative PANSS-derived factorial model provided the best fit to our data, (b) test its stability and (c) determine its clinical and demographic correlates.

methodA cohort of medication naive or minimally treated patients with first-episode schizophrenia (

resultsA nine-item PANSS model comprising social amotivation and expressive deficit dimensions outperformed the other models: comparative fit index = 0.98, goodness of fit index = 0.97, Tucker-Lewis index = 0.97, root mean square error of approximation = 0.06 (CI 90%: 0.04-0.08), Bayesian information criterion = 191.9, Akaike information criterion = 101.7. At baseline, the social amotivation dimension was associated with more severe depression whereas the expressive deficit dimension was associated with younger age. Both dimensions at baseline were associated with poor functioning, but expressive deficit to a lesser extent.

conclusionsA nine-item PANSS model incorporating social amotivation and expressive deficit dimensions appeared to best reflect the underlying structure of negative symptoms in our sample.

Indexed as

confirmatory factor analysisfirst-episode psychosisnegative symptom dimensionsNegative symptomsschizophrenia

Identifiers

PMID41384453
PMCPMC12724093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.